Genetic Insights Into AVP Deficiency: Identification of a Novel AVP Variant and Compilation of a Curated Catalogue of Pathogenic Variants.
Genetic testing now clarifies diagnosis of rare diabetes insipidus, helping doctors confirm suspected cases and guide lifelong desmopressin therapy confidently.
A novel AVP gene variant causing central diabetes insipidus is described alongside a comprehensive curated catalogue of pathogenic AVP variants, providing a diagnostic resource for this rare endocrine condition. This advances genetic diagnosis in a rare disease with established treatment (desmopressin) but often delayed genetic confirmation.
What the study was
- Study design
- Genetic case study + curated variant catalogue
- Population
- Patients with AVP deficiency (central diabetes insipidus); rare endocrine disease
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Clinical genetics
Why it surfaced
Rare disease genetic resource; low score due to limited clinical impact compared to other entries, but relevant for rare disease watchlist coverage.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.